Despite the biological functions of UBE2T have ever been well studied in breast cancer and Fanconi anemia [20, 21], none therapeutic inhibitors targeting UBE2T have been reported yet [45, 46]. The gene discussed is UBE2T; the disease is breast carcinoma.